It is a chemicals private limited company based in Gujarat, Gujarat, India, established in 1997.
1997 | Gujarat, Gujarat, India | ActiveFairfield Pharmaceuticals Private Limited, a active private limited company, was established on 27 October 1997 in Gujarat, Gujarat, India. Engaging in chemical products within the chemicals sector, it holds CIN: U24230GJ1997PTC033254. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Ghanshyam M Kunjadia (Director), Rekhaben Ghanshayambhai Kunjadia (Additional Director), Manubhai Maganbhai Kunjadiya (Director). Past directors included Mukeshkumar Maganbhai Kunjadiya. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 662 / 4306 Opp Bhakti Nagarbapunagar Ahmedabad, Gujarat, Gujarat, 380024.
U24230GJ1997PTC033254
033254
27 October 1997
₹0.50 M
₹0.50 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Fairfield Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ghanshyam M Kunjadia | Director | 21 May 1999 | Current |
| Rekhaben Ghanshayambhai Kunjadia | Additional Director | 07 Sep 2024 | Current |
| Manubhai Maganbhai Kunjadiya | Director | 20 Sep 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Sep 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Fairfield Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 81.46% increase. The company also saw a slight improvement in profitability, with a 7.27% increase in profit. The company's net worth moved up by a moderate rise of 3.67%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Fairfield Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Fairfield Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Fairfield Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fairfield Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Fairfield Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Rekhaben Ghanshayambhai Kunjadia was appointed as a Additional Director was appointed as a Additional Director on 07 Sep 2024 & has been associated with this company since 1 year 3 months . was documented.
Progress on Fairfield Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was documented.
The activity Manubhai Maganbhai Kunjadiya was appointed as a Director was appointed as a Director on 20 Sep 2013 & has been associated with this company since 12 years 2 months . was completed.
The activity Ghanshyam M Kunjadia was appointed as a Director was appointed as a Director on 21 May 1999 & has been associated with this company since 26 years 6 months . was completed.
Fairfield Pharmaceuticals Private Limited was registered on 27 Oct 1997 with Roc Ahmedabad & aged 28 years 1 month as per MCA records. was recorded as a recent event.
The CIN of Fairfield Pharmaceuticals Private Limited is U24230GJ1997PTC033254.
Fairfield Pharmaceuticals Private Limited is headquartered at 662 / 4306 Opp Bhakti Nagarbapunagar Ahmedabad, Gujarat, Gujarat, 380024.
Fairfield Pharmaceuticals Private Limited was incorporated on 27 October 1997.
The current directors of Fairfield Pharmaceuticals Private Limited are
The primary industry of Fairfield Pharmaceuticals Private Limited is Chemicals.
Fairfield Pharmaceuticals Private Limited is unlisted.
The authorized capital of Fairfield Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Fairfield Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX